[144] EverQuote, Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 notice for EverQuote, Inc. (EVER) shows a proposed sale of 1,291 common shares (restricted stock units) acquired on 08/20/2025 from the issuer, with an aggregate market value of $30,312.68. The sale is slated for 08/27/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The filer or related person previously completed Rule 10b5-1 sales totaling 7,305 shares in the prior three months (5,710 shares on 07/07/2025 for $140,291.27 and 1,595 shares on 06/16/2025 for $39,651.70). The securities to be sold were acquired as Restricted Stock Units and payment/settlement occurred on 08/20/2025. The filer certifies they are not aware of undisclosed material adverse information and references Rule 10b5-1 procedures in the form.
Positive
- Use of Rule 10b5-1 is documented for prior sales, indicating prearranged trading plans
- Full disclosure of acquisition and planned sale dates and broker details are provided
Negative
- Insider sold 7,305 shares during the past three months (5,710 on 07/07/2025 and 1,595 on 06/16/2025)
- Proposed additional sale of 1,291 RSUs valued at $30,312.68 may increase insider selling activity
Insights
TL;DR: Insider intends to sell recently vested RSUs and has executed prior 10b5-1 sales totaling 7,305 shares in the past three months.
The filing documents a routine Form 144 sale of 1,291 common shares (RSUs) acquired from the issuer on 08/20/2025 with planned execution on 08/27/2025 via Morgan Stanley Smith Barney LLC on NASDAQ. The record shows prior Rule 10b5-1 sales by the same individual on 06/16/2025 and 07/07/2025, indicating prearranged dispositions. From an investor-monitoring perspective, these are factual insider sell disclosures that may reflect liquidity actions tied to RSU vesting rather than ad hoc dispositions.
TL;DR: Filing is a standard insider notice; it confirms compliance with Rule 144 and notes 10b5-1 plan usage for prior sales.
The form identifies the securities as Restricted Stock Units acquired from the issuer and reports planned sale details and broker information. The inclusion of prior 10b5-1 sales and the signers attestation about lack of undisclosed material information are consistent with standard governance and disclosure practices. The filing does not present new operational or financial information about the company itself.